dis iscl closures
play

Dis iscl closures I have no relevant financial relationships with - PDF document

1/11/2018 Dis iscl closures I have no relevant financial relationships with the organizer of todays event. Alaska Board of Pharmacy Employed by Walmart. Richard Holt, BS Pharm, PharmD, MBA Vice-Chair I am a member of the Alaska


  1. 1/11/2018 Dis iscl closures • I have no relevant financial relationships with the organizer of today’s event. Alaska Board of Pharmacy • Employed by Walmart. Richard Holt, BS Pharm, PharmD, MBA Vice-Chair • I am a member of the Alaska Pharmacist’s Association. Alaska Board of Pharmacy February 10, 2018 Alaska Board of Pharmacy February 10, 2018 Dis iscl claim imer Dis iscl claim imer This is not a Board of Pharmacy meeting. If the regulations presented in this CE are current and active they will be represented with their actual regulation number, Any feedback on regulation presented during i.e. 12 AAC …. this CE does not represent your official position to the Board of Pharmacy. To express your official position you must do so during a Otherwise, all regulations presented are publicly notified Board of Pharmacy meeting ongoing discussions by the Board and during the public comment period. represent a draft. Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 Goals and Objectives Boa Board Comp Composit ition 7 members • To review the current composition of the Board of Pharmacy. • To review regulations: • SB74 and HB159; • Emergency Preparedness; • Nationally Certified Pharmacy Technicians; • License Requirements for Individual Pharmacists Working for Tribal Health Programs; • Control Substance Prescription Drug Orders; • Refills; • Collaborative Practice Agreements; • Substitution; and • Return or Exchange of Drugs. Alaska Board of Pharmacy February 10, 2018 1

  2. 1/11/2018 Boa Board Comp Composit ition Ques esti tion How many board members are required to sign an application 2 members 5 members before it can be approved? a) 1 b) 2 Leif Holm (North Pole) Anne Gruening (Juneau) c) 3 James Henderson 1 Vacant (Soldotna) d) 4 Phil Sanders (Soldotna) e) 5 Lana Bell (Anchorage) Richard Holt (Eagle River) Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 Ques esti tion Sec ec. . 08 08.80 80.0 .070: : Quorum • Four members constitute a quorum for the transaction of How many board members are required to sign an application business. before it can be approved? • However, when the board meets for the purpose of examining a) 1 applications for licensure, three members of the board b) 2 constitute a quorum. c) 3 d) 4 e) 5 when the board meets for the purpose of examining applications for licensure, three members of the board constitute a quorum. Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 REGISTRATIO RE ION wit with PDMP RE REGISTRATIO ION wit with PDMP (a) A licensed pharmacist shall register with the Prescription Drug (c) After completing the registration requirements, a pharmacist or Monitoring Program’s controlled substance prescription database practitioner required to register with the PDMP will be issued a (PDMP) before dispensing a schedule II, III, or IV controlled user account, login name, and password by the department. substance under federal law. . (d) A pharmacist or practitioner required to register with the (b) Before dispensing, prescribing, or administering a schedule II, PDMP must access information in the PDMP using the user III, or IV controlled substance under federal law, a pharmacist or account, login name, and password issued by the department. practitioner required to register with the PDMP must (e) A pharmacist or practitioner required to register with the PDMP (1) register online on the PDMP website; and may access information in the PDMP using another registrant’s (2) pay the fee established in 12 AAC 02.310. credentials only as authorized by a contract executed by the department for the purposes of AS 47.07.038. Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 2

  3. 1/11/2018 REP REPORTIN ING & & REVI REVIEWIN ING th the e ACCE CCESSIN ING th the e PDMP PDMP For the purposes of AS 17.30.200(d)(3) and (4), a licensed practitioner or licensed or registered pharmacist authorizing an (a) Unless excused from reporting under AS 17.30.200(u), “agent or employee” to access the PDMP is responsible for information required under AS 17.30.200(b) must be submitted by a pharmacist, if the pharmacist-in-charge is not present. maintaining and terminating the agent or employee’s access to the PDMP. (b) Unless excused from reporting under AS 17.30.200(u), a pharmacist or practitioner required to submit information under AS 17.30.200(b) must submit the information to the Alaska Prescription Drug Monitoring Program (PDMP) daily as of the previous submission date. DAILY: becomes law July 1, 2018. Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 REP REPORTIN ING & & REVI REVIEWIN ING th the e REPORTIN REP ING & & REVI REVIEWIN ING th the e PDMP PDMP (c) The time computation under 12 AAC 02.920(b) applies to a submission of information (f) Unless excused from reporting under AS 17.30.200(u), or a waiver is granted under 12 under AS 17.30.200(b) and this section. AAC 52.870, a pharmacist or practitioner required to submit information under AS 17.30.200(b)must submit the information to the PDMP electronically through the website provided by the board. ( d) For the purposes of AS 17.30.200(b)(8), “other appropriate identifier” and “other appropriate identifying information” means the state issued license number of the prescribing practitioner, and the dispensing pharmacist or practitioner. (g) Unless excused from reviewing the PDMP under AS 17.30.200(k)(4)(A) – (B), a practitioner, but not a pharmacist, must review the information in the PDMP to check a patient's prescription records before dispensing, prescribing, or administering a schedule (e) Within 72 hours of discovering an error in information submitted under AS II or III controlled substance under federal law. 17.30.200(b), a pharmacist or practitioner required to submit the information under AS 17.30.200(b) must submit information correcting the error to the PDMP administrator. The time computation under 12 AAC 02.920(b) applies to a submission of information correcting an error in information submitted under AS 17.30.200(b). Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 Init itial l Quanti tity ty of f Opio ioid ids: Grounds for Dis isci ciplin ine 9/19 9/ 19/2 /201 017 7 BO BOP Statem ement A violation of 12 AAC 52.855 — 12 AAC 52.890 by a pharmacist is grounds for the imposition of disciplinary sanctions under AS 08.01.075 and AS 08.80.261. Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 3

  4. 1/11/2018 Init itial l Quanti tity ty of f Opio ioid ids: Ques esti tion 9/ 9/19 19/2 /201 017 7 BO BOP Statem ement True or False. Emergency Preparedness already exist in AS 08.80? a) True b) False Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 Emer ergency Prep eparedness ss Emer ergency Prep eparedness ss Results in pharmacist being authorized to dispense up to a 30- The Emergency Preparedness Regulations being discussed day supply of medication if: currently address: • In RPh professional opinion the medication is essential to • Redefining 12 AAC 52.110 (Emergency Pharmacist Permit); the maintenance of life or to the continuation of therapy and • A natural disaster, terrorist attack or state emergency declared the by Governor of Alaska; • The order is reduced to writing marked “emergency prescription” and filed according to existing regulations. • A natural disaster, terrorist attack or state emergency declared by another state’s Governor resulting in patients being temporarily If the declared state of emergency continues for more than 21-days relocated to Alaska; after the emergency 30-day dispensing, one additional dispensing of up to a 30-day supply may be dispensed. Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 License Req equirements for r RPh Ques esti tion Work rking for r Tribal Heal ealth Pr Programs True or False. • For many years, the Board has been working on attempting to understand what pharmacists are living and practicing within Emergency Preparedness already exist in AS 08.80? the State under another State’s license and create regulations to make such pharmacists known. a) True b) False • AGO AN2009102500, April 17 2012. Located within “Frequently Asked Questions” on Board of Pharmacy website. They are currently being drafted but do not currently exist in • Not unique to the Board of Pharmacy: 12 AAC 40.981 regulation. Alaska Board of Pharmacy Alaska Board of Pharmacy February 10, 2018 February 10, 2018 4

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend